Back to Journals » Drug Design, Development and Therapy » Volume 9

Original Research

A phase I/II study of biweekly capecitabine and irinotecan plus bevacizumab as second-line chemotherapy in patients with metastatic colorectal cancer

       
Total article views   HTML views PDF downloads Totals
12,557 Dovepress* 11,294+ 1,750 13,044
PubMed Central* 1,263 493 1,756
Totals 12,557 2,243 14,800
*Since 16 March 2015
+Since July 2016

View citations on PubMed Central and Google Scholar